Fact CheckerSign in

NCT06929650Recruiting

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

Thermo-Ablation With Radiofrequency Medical Technologies to Treat Thyroid Cancers

Source: ClinicalTrials.gov · Last updated 16 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)? Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
31 Mar 2025
Start date
20 Apr 2023
Primary completion date
31 Dec 2025
Lead sponsor
University Health Network, Toronto
NCT number
NCT06929650

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 20 Apr 2023 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously treated for thyroid cancer

Other illness

  • Any concern for invasive or metastatic thyroid cancer

Age

  • Patients \<18 years old

Other

  • Pregnant women

Who the study is looking for

  • 1\. Patients with:
  • Nodule less than or equal to 2cm in size
    • Specifically: Bethesda 5/6
  • Their age is ≥18 years and ≤100 years
  • Able to provide written consent
  • Able to attend required follow-ups as per the protocol

Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Health Network
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.